Welcome Guest
Home > Clinical Genitourinary Cancer > Volume 3 |  Issue 2

Table of Contents

Volume 3 |  Issue 2

Publication Date: September 2004
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Editorial
Page Number of this Article in the Print Version
71-72		 Prostate Cancer and Bone: A Unique Relationship with Multiple Opportunities for Targeted Therapy
Oliver Sartor
  • Abstract
  • No Access
  • Add to Cart
Meeting Highlights
Page Number of this Article in the Print Version
73-76		 Highlights from: the 40th Annual Meeting of the American Society of Clinical Oncology; New Orleans, LA; June 2004
David Lee, Nancy Price, G. Kesava Reddy, Oliver Sartor, Vinay K. Jain
  • Abstract
  • No Access
  • Add to Cart
Researches in Brief
Page Number of this Article in the Print Version
77-79		 Benefit of Extended Zoledronate Therapy for Patients with Bone Metastases from Hormone-Refractory Prostate Cancer
Nancy Price, Oliver Sartor, Vinay K. Jain
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
80-82		 Activity of Epothilone B Analogues Ixabepilone and Patupilone in Hormone-Refractory Prostate Cancer
David Lee, Oliver Sartor, Vinay K. Jain
  • Abstract
  • No Access
  • Add to Cart
Comprehensive Reviews
Page Number of this Article in the Print Version
83-86		 Double Primary Cancers of the Prostate and Bladder: A Literature Review
Yoshihisa Kinoshita, Amar Singh, Peter M. Rovito, Jr, Ching Y. Wang, Gabriel P. Haas
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
87-92		 Current Concepts in the Management of Erectile Dysfunction in Men with Prostate Cancer
Muammer Kendirci, Wayne J.G. Hellstrom
  • Abstract
  • No Access
  • Add to Cart
Original Contribution
Page Number of this Article in the Print Version
93-97		 Effect of Pelvic Lymph Node Irradiation in Salvage Therapy for Patients with Prostate Cancer with a Biochemical Relapse Following Radical Prostatectomy
Brian S. Kim, Ashkan Lashkari, Roy Vongtama, Steve P. Lee, Robert G. Parker
  • Abstract
  • No Access
  • Add to Cart
Comprehensive Review
Page Number of this Article in the Print Version
98-103		 Absence of a Correlation of Androgen Receptor Gene CAG Repeat Length and Prostate Cancer Risk in an African-American Population
Timothy Gilligan, Judith Manola, Oliver Sartor, Sally P. Weinrich, Judd W. Moul, Philip W. Kantoff
  • Abstract
  • No Access
  • Add to Cart
Original Contribution
Page Number of this Article in the Print Version
104-111		 Phase II Randomized Trial of Weekly Paclitaxel with or Without Estramustine Phosphate in Progressive, Metastatic, Hormone-Refractory Prostate Cancer
William R. Berry, James W. Hathorn, Shaker R. Dakhil, David M. Loesch, Don V. Jackson, Mary Ann Gregurich, Jennifer K. Newcomb-Fernandez, Lina Asmar
  • Abstract
  • No Access
  • Add to Cart
Translational Medicine
Page Number of this Article in the Print Version
112-121		 Anti-CD3 × Anti-HER2 Bispecific Antibody Effectively Redirects Armed T Cells to Inhibit Tumor Development and Growth in Hormone-Refractory Prostate Cancer-Bearing Severe Combined Immunodeficient Beige Mice
Pamela A. Davol, Janelle A. Smith, Nicola Kouttab, Gerald J. Elfenbein, Lawrence G. Lum
  • Abstract
  • No Access
  • Add to Cart
Brief Communication
Page Number of this Article in the Print Version
122-124		 Second-Line Chemotherapy for Hormone-Refractory Prostate Cancer: Has the Time Come?
Jonathan E. Rosenberg, Eric J. Small
  • Abstract
  • No Access
  • Add to Cart